Biotech funds see $1.5 billion outflows in latest week says Raymond James

Investing.com -- Healthcare and biotech-focused mutual funds and ETFs recorded net outflows of $1.5 billion for the week ending Wednesday, according to data from Raymond James.

The outflows represented a 1.53% decrease in assets across 130 funds managing approximately $99.5 billion. Year-to-date net outflows have reached $1.98 billion.

This marks the second consecutive week of outflows from the sector.

The breadth ratio, which measures the number of funds experiencing inflows divided by those seeing outflows, increased to 0.48 from 0.45 the previous week.

Raymond James noted that when the breadth ratio reaches 0.3, the biotech sector has historically rallied by an average of 17.5% over the following six months. The ratio hit 0.28 on July 16, and the Nasdaq Biotechnology Index has risen approximately 36% since that date.

You May Also Be Interested In

• Oman Warned European Allies Ship Fees Likely Needed For Hormuz - Bloomberg
• Roku to spend $25M on child privacy features in Florida settlement
• Micron Technology (MU) call put ratio 1.4 calls to 1 put with a focus on 1K contracts of July 2 weekly 150 puts